ConductScience.org, home

Paper24736743

A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.

Knudson SE and 8 others. PLoS One, 2014. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis. Papers, record 24736743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24736743

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.
PubMed
Journal
PLoS One
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knudson SESusan E
2Awasthi DDivya
3Kumar KKunal
4Carreau AAlexandra
5Goullieux LLaurent
6Lagrange SSophie
7Vermet HHélèn
8Ojima IIwao
9Slayden RARichard A

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
BenzimidazolesMajor topic
Cell DivisionMajor topic
Mycobacterium tuberculosisMajor topic
Animals
Bacterial Proteins
Cytoskeletal Proteins
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Stability
Humans
Mice
Microbial Sensitivity Tests
Molecular Structure
Protein Multimerization
Rifamycins
Treatment Outcome
Tuberculosis

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AI082164NIAID NIH HHSUnited StatesU01AI082164PubMed and NIHNIH RePORTER
AIO78251PHS HHSUnited StatesPubMedPubMed
AI082164NIAID NIH HHSUnited StatesU01AI082164PubMed and NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122535945Complete annotated genome sequence of Mycobacterium tuberculosis Erdman.J Bacteriol2012https://conductscience.org/library/papers/22535945PubMed
222024272Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.Bioorg Med Chem2011https://conductscience.org/library/papers/22024272PubMed
320385864In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20385864PubMed
417664324Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17664324PubMed
517301295XDR tuberculosis--implications for global public health.N Engl J Med2007https://conductscience.org/library/papers/17301295PubMed
618479968Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery.Tuberculosis (Edinb)2008https://conductscience.org/library/papers/18479968PubMed
717346197FtsZ: a novel target for tuberculosis drug discovery.Curr Top Med Chem2007https://conductscience.org/library/papers/17346197PubMed
823623254Benzimidazole-based antibacterial agents against Francisella tularensis.Bioorg Med Chem2013https://conductscience.org/library/papers/23623254PubMed
923647650A novel quinoline derivative that inhibits mycobacterial FtsZ.Tuberculosis (Edinb)2013https://conductscience.org/library/papers/23647650PubMed
1016420032Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.J Med Chem2006https://conductscience.org/library/papers/16420032PubMed
1112368430Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv.Microbiology (Reading)2002https://conductscience.org/library/papers/12368430PubMed
1224266862SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.J Med Chem2013https://conductscience.org/library/papers/24266862PubMed
1316735741Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis.Microbiology (Reading)2006https://conductscience.org/library/papers/16735741PubMed
1421339840Discovery of anti-TB agents that target the cell-division protein FtsZ.Future Med Chem2010https://conductscience.org/library/papers/21339840PubMed
1511069675Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.Mol Microbiol2000https://conductscience.org/library/papers/11069675PubMed
169145860Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9145860PubMed
1712543692Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12543692PubMed
1817868596First tuberculosis cases in Italy resistant to all tested drugs.Euro Surveill2007https://conductscience.org/library/papers/17868596PubMed
1921126020Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.J Med Chem2011https://conductscience.org/library/papers/21126020PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
40827962Microbiological evidence for the trisubstituted benzimidazoles targeting MmpL3 in Mycobacterium tuberculosis.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40827962PubMed
34835459Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs.Microorganisms2021https://conductscience.org/library/papers/34835459PubMed
34031040Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus.J Bacteriol2021https://conductscience.org/library/papers/34031040PubMed
31882782Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens.Sci Rep2019https://conductscience.org/library/papers/31882782PubMed
31045565Novel T9 loop conformation of filamenting temperature-sensitive mutant Z from Mycobacterium tuberculosis.Acta Crystallogr F Struct Biol Commun2019https://conductscience.org/library/papers/31045565PubMed
28555087Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ.J Fluor Chem2017https://conductscience.org/library/papers/28555087PubMed
27865404Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.Tuberculosis (Edinb)2016https://conductscience.org/library/papers/27865404PubMed
27301676Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.Bioorg Med Chem2016https://conductscience.org/library/papers/27301676PubMed
27189886Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.Bioorg Med Chem2016https://conductscience.org/library/papers/27189886PubMed
26756351Targeting the Bacterial Division Protein FtsZ.J Med Chem2016https://conductscience.org/library/papers/26756351PubMed
26245639Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.J Antimicrob Chemother2015https://conductscience.org/library/papers/26245639PubMed
25293977Antimicrobial activity of a quinuclidine-based FtsZ inhibitor and its synergistic potential with β-lactam antibiotics.J Antibiot (Tokyo)2015https://conductscience.org/library/papers/25293977PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24736743

GET https://conductscience.org/api/papers/v1/24736743/authors